Skip to main content

Table 3 Subanalyses according to type of staphylococci

From: Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial

a   Success Failure
Rifampicin group MSSA 14/18 4/18
MRSE 3/5 2/5
Monotherapy group MSSA 13/20 7/20
MRSE 5/5 0/5
Total MSSA 27/38 11/38
MRSE 8/10 2/10
  1. aMSSA methicillin-susceptible S. aureus, MRSE methicillin-resistant S. epidermidis